Health tech SPAC OS Acquisition withdrew its IPO registration

Health tech SPAC OS Acquisition withdrew its IPO registration

Health tech SPAC OS Acquisition withdrew its IPO registration.
Sections
Axios Local
Axios gets you smarter faster with news & information that matters
About
Subscribe

OS Acquisition pulls out

Illustration: Aïda Amer/AxiosExit Content Preview OS Acquisition, a health tech SPAC led by OS Fund's Jeff Klunzinger, on Wednesday withdrew registration for a $150 million IPO. Why it matters: The withdrawal is yet another reflection of the 180-degree turn in the market that once had a spate of exuberant digital health companies file to go public and is now racked with cancellations and delistings. Catch up quick: OS Acquisition filed in March 2021 to raise $150 million by offering 15 million units at $10, with each unit containing one share of common stock and one-third of a warrant.The Park Ridge, Illinois-based company planned to list on the Nasdaq under the symbol OSAAU with Citi as sole bookrunner and to acquire a health tech company, Renaissance Capital.In addition to Klunzinger, the business would be led by CFO and OS Fund partner Mark Ghobrial. Zoom in: Health tech founder Bryan Johnson created OS Fund in 2014 with $100 million of his own investment funds, and a host of Klunzinger-backed startups that met the investment thesis that biology is a programmable form of technology, much like other operating systems. Its portfolio companies span genomics, synthetic biology, therapeutics, materials and diagnostics.That includes Bill Gates-backed Ginkgo Bioworks, which last year with a total market cap of more than $17 billion, and Synthego, a Peter Thiel-backed developer of plug-and-play Crispr kits for researchers.Johnson is also the founder of brain machine interface developer Kernel. Of note: The SPAC market took in the form of a 1% excise tax on stock buybacks, as introduced by the Inflation Reduction Act.SPAC liquidations is where the tax could be most acutely felt. With too many blank-check companies chasing too few targets, we're likely to see liquidations — and withdrawals — continue.
Go deeper
Share:
0 comments

Comments (0)

Leave a Comment

Minimum 10 characters required

* All fields are required. Comments are moderated before appearing.

No comments yet. Be the first to comment!